The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Based on available information, a cause for the reported hemorrhage could not be determined.The reported patient effect of hemorrhage is listed in the mitraclip system instructions for use, and is a known possible complication associated with mitraclip procedures.The reported additional therapy/non-surgical treatment was a result of case-specific circumstances, as the right groin was treated to stop the bleeding.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
This is being filed to report the bleeding requiring intervention.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with a grade of 4.During insertion of the steerable guide catheter (sgc), arterial bleeding occurred therefore the sgc was removed.The access site was switched to the left groin and the procedure continued with a new sgc.Two clips were implanted, reducing mr to 2.After the procedure, the right groin was treated to stop the bleeding.There was no clinically significant delay in the procedure and no adverse patient sequela.No additional information was provided.
|